Search

Your search keyword '"Navani N."' showing total 348 results

Search Constraints

Start Over You searched for: Author "Navani N." Remove constraint Author: "Navani N."
348 results on '"Navani N."'

Search Results

1. UK Stakeholder Perspectives on Surrogate Endpoints in Cancer, and the Potential for UK Real-World Datasets to Validate Their Use in Decision-Making

2. Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling

3. The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma

5. Body composition and lung cancer-associated cachexia in TRACERx

6. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

7. Genomic–transcriptomic evolution in lung cancer and metastasis

8. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA

9. Antibodies against endogenous retroviruses promote lung cancer immunotherapy

10. The evolution of lung cancer and impact of subclonal selection in TRACERx

14. The role of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of mediastinal lymphadenopathy

15. The evolution of lung cancer and impact of subclonal selection in TRACERx

28. 135P The real-world use of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor mutated (EGFRm) advanced (stage IIIb/IIIc/IV) non-small cell lung cancer (NSCLC) patients

29. 143P Physician perceptions of barriers to epidermal growth factor receptor mutation (EGFRm) testing in advanced (stage IIIb/IIIc/IV) non-small cell lung cancer (NSCLC)

30. 144P Delays in epidermal growth factor receptor mutation (EGFRm) testing in advanced (stage IIIb/ IIIc/ IV) non-small cell lung cancer (NSCLC) patients and their impact on the use of first line tyrosine kinase inhibitor (TKIs) in a real-world setting

34. Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer

35. Effect of delays in the UK two-week wait cancer referral pathway during the COVID-19 pandemic on cancer survival: a modelling study

36. P18 The SUMMIT study: uptake from re-invitation

37. S73 Brain imaging in the management of people with lung cancer prior to therapy with curative intent: multi-centre review of the assumptions made in the NICE guideline NG122 evidence review

38. Corrigendum to “73 - Five years of stereotactic radiotherapy for early lung cancer: Biopsy rates, outcomes and implications” [Lung Cancer, 139, 1, (January 2020) Page S31]

47. Patient deprivation and perceived scan burden negatively impact the quality of whole-body MRI

50. SUMMIT study: management of extrapulmonary incidental findings in a lung cancer screening cohort

Catalog

Books, media, physical & digital resources